Nichols & Pratt Advisers LLP Repligen Corp Transaction History
Nichols & Pratt Advisers LLP
- $1.45 Billion
- Q1 2024
A detailed history of Nichols & Pratt Advisers LLP transactions in Repligen Corp stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 2,555 shares of RGEN stock, worth $309,027. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,555
Previous 2,555
-0.0%
Holding current value
$309,027
Previous $459,000
2.18%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding RGEN
# of Institutions
521Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$940 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$617 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$432 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$213 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$177 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.71B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....